Sui Generis Health Holding Company

sui generis health (sgh) commercializes/monetizes products and/or services that are aligned with the predictive-preventive, clinical & financial mandates contained within the ppaca - specifically with platforms that focus on chronic condition population management. we review for scientific/clinical validity, clinical utility and predictive analytics to include the cascading economic impact on gain-share/p4p. this is performed in accordance to existing legislative and medical policy development requirements as established/followed by cms/va/commercial insurance carriers. the review is performed by nationally recognized subject matter experts and any/all products and/or services must meet or exceed all standards in order to be accepted as a client of sgh.